Climb Bio, Inc. (CLYM)
9.18
-0.10
(-1.08%)
USD |
NASDAQ |
Nov 20, 16:00
9.18
0.00 (0.00%)
After-Hours: 16:33
Climb Bio Total Assets (Quarterly) : 236.56M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 236.56M |
| June 30, 2026 | 246.29M |
| March 31, 2026 | 152.37M |
| December 31, 2025 | 167.74M |
| September 30, 2025 | 182.30M |
| June 30, 2025 | 192.39M |
| March 31, 2025 | 200.74M |
| December 31, 2024 | 217.19M |
| September 30, 2024 | 222.20M |
| June 30, 2024 | 226.02M |
| March 31, 2024 | 109.33M |
| December 31, 2023 | 110.47M |
| Date | Value |
|---|---|
| September 30, 2023 | 112.74M |
| June 30, 2023 | 116.27M |
| March 31, 2023 | 122.08M |
| December 31, 2022 | 134.99M |
| September 30, 2022 | 140.86M |
| June 30, 2022 | 150.10M |
| March 31, 2022 | 162.42M |
| December 31, 2021 | 173.24M |
| September 30, 2021 | 182.25M |
| June 30, 2021 | 107.63M |
| March 31, 2021 | 53.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | 462.08M |
| Cullinan Therapeutics, Inc. | 322.56M |
| Q32 Bio, Inc. | 297.20M |
| Oncolytics Biotech, Inc. | 5.832M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.511M |
| Shareholders Equity (Quarterly) | 228.05M |
| Debt to Equity Ratio | 0.0047 |
| Current Ratio | 26.58 |
| Net Debt Paydown Yield | -0.01% |